Terry-Ann Burrell - Jan 26, 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Financial Officer
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Jan 26, 2023
Transactions value $
-$1,169,875
Form type
4
Date filed
1/30/2023, 03:05 PM
Previous filing
Jan 25, 2023
Next filing
Apr 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $15.1K +1.1K +3.52% $13.68 32.4K Jan 26, 2023 Direct F1
transaction BEAM Common Stock Sale -$49.8K -1.1K -3.4% $45.16 31.3K Jan 26, 2023 Direct F2, F3
transaction BEAM Common Stock Options Exercise $495K +36.2K +115.59% $13.68 67.4K Jan 27, 2023 Direct F1
transaction BEAM Common Stock Sale -$1.63M -36.2K -53.61% $45.08 31.3K Jan 27, 2023 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -1.1K -0.49% $0.00 222K Jan 26, 2023 Common Stock 1.1K $13.68 Direct F1, F5
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -36.2K -16.31% $0.00 186K Jan 27, 2023 Common Stock 36.2K $13.68 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.48, inclusive. The Reporting Person undertakes to provide Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.24, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested.